Pacer Advisors, Inc. Cel Sci Corp Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$8.68 - $27.49 $29,355 - $92,971	-3,382 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$12.0 - $27.64 $9,960 - $22,941	830 Added 32.52%	3,382 $51,000
Q4 2020 Jan 20, 2021	SELL	$11.05 - $16.62 $13,149 - $19,777	-1,190 Reduced 31.8%	2,552 $30,000
Q3 2020 Oct 19, 2020	BUY	$11.69 - $14.54 $43,743 - $54,408	3,742 New	3,742 $48,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.